HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 3.15
Day range
kr 3.13 - kr 3.23
Year range
kr 2.05 - kr 5.23
Market cap
407.71M SEK
Avg Volume
1.85M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.13M | 104.01% |
Net income | -22.98M | -73.18% |
Net profit margin | — | — |
Earnings per share | -0.20 | 48.72% |
EBITDA | -23.11M | -104.18% |
Effective tax rate | 0.94% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.44M | 103.00% |
Total assets | 125.33M | 31.99% |
Total liabilities | 31.62M | -33.11% |
Total equity | 93.71M | — |
Shares outstanding | 112.96M | — |
Price to book | 3.80 | — |
Return on assets | -46.58% | — |
Return on capital | -61.86% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -22.98M | -73.18% |
Cash from operations | -17.99M | -50.32% |
Cash from investing | -57.00K | — |
Cash from financing | 21.33M | 41.32% |
Net change in cash | 3.14M | -2.78% |
Free cash flow | -28.07M | -293.60% |
About
Founded
1999
Website
Employees
11
